Fox D, Kouris G J, Blumofe K A, Heilizer T J, Husak V, Greisler H P
Department of Surgery, Loyola University Medical Center, Maywood, Illinois 60153, USA.
J Surg Res. 1999 Sep;86(1):9-16. doi: 10.1006/jsre.1999.5597.
The fluorescent marker PKH26 has been demonstrated to be useful for the tracking of endothelial cells in short-term studies; however, the optimal labeling conditions for long-term implants have not been determined. This study was designed to evaluate the effects of PKH26 on endothelial cell proliferation and to identify labeling conditions that would yield the greatest fluorescence over time without adversely affecting cell viability.
Canine jugular vein endothelial cells (CJVECs) were labeled with 0. 04 microM PKH26. Proliferation of labeled and control cells was assessed for 8 consecutive days by [(3)H]thymidine uptake. In a second experiment, CJVECs were labeled at concentrations of 0, 5, 8, 10, and 20 micromol/L. Cells were maintained in culture for 60 days. The fluorescence intensity of each cell population was measured using two techniques. At baseline and at 60 days, fluorescence was measured using a fluorescence-activated cell sorter. On days 14, 28, 45, and 60 fluorescence was measured by constructing gray-scale histograms from photomicrographs taken of each flask under rhodamine illumination. Mean viable cell number for each concentration was determined after 60 days.
In the first experiment, PKH26-labeled and unlabeled CJVECs demonstrated nearly identical growth curves, suggesting that PKH26 had no adverse effect on proliferation. In the second experiment, after 60 days, the 10 and 20 microM groups displayed greater fluorescence by histogram than the 0, 5, or 8 microM groups; however, they were not significantly different from each other (mean intensity 8.2 vs 9.1, P > 0.05, Student-Newman-Keuls test for multiple comparisons). Over 60 days, the cells labeled with 20 microM PKH26 experienced the only significant decrease in viable cells compared to the unlabeled group (5.5 x 10(5) vs 9.6 x 10(5) cells/flask, P < 0.05). Importantly, we observed no significant differences in cell number between the 10 microM group and the lower concentrations compared to the unlabeled cells (P > 0.05).
We conclude that a concentration of 10 microM PKH26 provides the optimal labeling condition for endothelial cells when long-term tracking is desired.
荧光标记物PKH26已被证明在短期研究中可用于追踪内皮细胞;然而,长期植入的最佳标记条件尚未确定。本研究旨在评估PKH26对内皮细胞增殖的影响,并确定能在不影响细胞活力的情况下随时间产生最大荧光的标记条件。
用0.04微摩尔/升的PKH26标记犬颈静脉内皮细胞(CJVECs)。通过[³H]胸腺嘧啶核苷摄取连续8天评估标记细胞和对照细胞的增殖情况。在第二个实验中,以0、5、8、10和20微摩尔/升的浓度标记CJVECs。将细胞培养60天。使用两种技术测量每个细胞群体的荧光强度。在基线和60天时,使用荧光激活细胞分选仪测量荧光。在第14、28、45和60天,通过对每个培养瓶在罗丹明光照下拍摄的显微照片构建灰度直方图来测量荧光。60天后确定每个浓度的平均活细胞数。
在第一个实验中,PKH26标记的和未标记的CJVECs显示出几乎相同的生长曲线,表明PKH26对增殖没有不利影响。在第二个实验中,60天后,10和20微摩尔/升组通过直方图显示的荧光比0、5或8微摩尔/升组更强;然而,它们之间没有显著差异(平均强度8.2对9.1,P>0.05,采用Student-Newman-Keuls多重比较检验)。在60天内,与未标记组相比,用20微摩尔/升PKH26标记的细胞是唯一活细胞数量显著减少的组(5.5×10⁵对9.6×10⁵个细胞/培养瓶,P<0.05)。重要的是,与未标记细胞相比,我们观察到10微摩尔/升组与较低浓度组之间的细胞数量没有显著差异(P>0.05)。
我们得出结论,当需要长期追踪时,10微摩尔/升的PKH26浓度为内皮细胞提供了最佳标记条件。